Zenith Drugs Limited — Others, 13-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Zenith Drugs Limited has submitted a certificate for compliance under Regulation 74(5) of SEBI for the quarter ended December 31, 2024. The company confirmed that all shares are held in dematerialized form, with no requests for rematerialization received during the period. This update reinforces the company’s operational efficiency and commitment to shareholder convenience.

From an investor perspective, maintaining a fully electronic shareholding structure could enhance liquidity and reduce transaction costs, potentially fostering a positive outlook among current and prospective shareholders.